West Pharmaceutical Services (WST) Research & Development (2009 - 2026)

West Pharmaceutical Services has disclosed Research & Development across 18 years of filings, most recently posting $19.7 million for Q2 2026.

• In Q2 2026, Research & Development rose 3.14% year-over-year to $19.7 million; the TTM figure through Jun 2026 stood at $74.4 million (up 7.2% YoY), while the FY2025 annual figure was $74.3 million, up 7.53% from the prior year.
• Research & Development came in at $19.7 million for Q2 2026 at West Pharmaceutical Services, up from $15.8 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $21.8 million in Q4 2025 to a low of $13.6 million in Q3 2022.
• Average Research & Development over 5 years is $17.0 million, with a median of $16.8 million recorded in 2023.
• Year-over-year, Research & Development climbed 20.59% in 2023 and slipped 7.39% in 2025.
• Over 5 years, Research & Development stood at $15.9 million in 2022, then grew by 15.72% to $18.4 million in 2023, then climbed by 0.54% to $18.5 million in 2024, then advanced by 17.84% to $21.8 million in 2025, then decreased by 9.63% to $19.7 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $19.7 million in Q2 2026, $15.8 million in Q1 2026, and $21.8 million in Q4 2025.